This page shows the details of why an item matched the keywords from your search.
| Property | Value |
|
has major subject area list
|
Cardiovascular Diseases; Molecular Targeted Therapy; Proprotein Convertases
|
|
has minor subject area list
|
Adipocytes; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Brain; Cholesterol, LDL; Clinical Trials as Topic; Genetic Predisposition to Disease; Humans; Hyperlipoproteinemias; Incidence; Intestinal Mucosa; Liver; Mice; Mutation; Oligonucleotides, Antisense; Peptide Fragments; Proprotein Convertase 9; Protein Structure, Tertiary; Receptors, LDL; RNA Interference; RNA, Small Interfering; Serine Endopeptidases; Structure-Activity Relationship
|
|
information resource reference
|
Proprotein convertase subtilisin/kexin type 9 inhibition: a new therapeutic mechanism for reducing cardiovascular disease risk. Circulation. 2015 Oct 27; 132(17):1648-66.
|
|
label
|
Proprotein convertase subtilisin/kexin type 9 inhibition: a new therapeutic mechanism for reducing cardiovascular disease risk.
|